Journal
HEALTHCARE
Volume 10, Issue 4, Pages -Publisher
MDPI
DOI: 10.3390/healthcare10040661
Keywords
breast cancer; anxiety; depression; longitudinal study; trajectory
Funding
- European Regional Development Funds [POCI-01-0145-FEDER016867]
- FundacAo para a Ciencia e a Tecnologia (FCT) [PTDC/DTP-EPI/7183/2014]
- FCT under EPIUnit-Instituto de Saude Publica da Universidade do Porto [UIDB/04750/2020]
- Laboratorio para a InvestigacAo Integrativa e Translacional em Saude Populacional [LA/P/0064/2020]
- FCT [PTDC/SAU-EPI/6275/2020, POCI-01-0145-FEDER-032358, PTDC/SAU-EPI/32358/2017]
- Chair on Pain Medicine of the Faculty of Medicine, University of Porto
- Grunenthal Foundation-Portugal
- Fundação para a Ciência e a Tecnologia [PTDC/SAU-EPI/32358/2017, PTDC/SAU-EPI/6275/2020, PTDC/DTP-EPI/7183/2014] Funding Source: FCT
Ask authors/readers for more resources
This study aimed to identify the trajectories of anxiety and depression symptoms among breast cancer patients in the span of five years. The results showed that the majority of patients had stable anxiety and depression symptoms over the five-year period, while a small portion experienced either increasing or decreasing symptoms. Age, education, baseline, and one-year status of anxiety and depression could predict the worst trajectories over five years.
Anxiety and depression symptoms are frequent among patients with breast cancer (BCa) and may last after initial treatments. We aimed to identify five-year trajectories of anxiety and depression symptoms among women with BCa. Neuro-oncological complications of BCa (NEON-BC) cohort included 506 patients admitted at the Portuguese Institute of Oncology of Porto in 2012, who were evaluated with the Hospital Anxiety and Depression Scale before cancer treatment and after one, three, and five years (7.9% attrition rate). Mixed-effect models were used to model anxiety and depression scores over time and model-based clustering to identify the different trajectories. Three trajectories of anxiety symptoms were identified: (1) high scores at baseline and increasing over time (21.7%); (2) consistently low scores over time (63.6%); (3) mid-range scores at baseline, decreasing over time (14.6%). Three trajectories were identified for depression symptoms: (1) high scores at baseline and increasing over time (21.1%); (2) mid-range scores at baseline, which decreased afterward (58.7%); (3) consistently low levels over time (20.2%). Age, education, baseline, and one-year anxiety/depression status predicted the worst five-year trajectories. These results show that assessing anxiety and depression symptoms before treatment and after one year may contribute to identifying the patients who could benefit the most from psychological support.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available